Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MPPE1 pseudogene 2 (MPPE1P2) is classified as a **pseudogene**—a segment of DNA related to the protein-coding MPPE1 gene but does not encode a functional protein. Pseudogenes, including MPPE1P2, typically arise via mutation, duplication, or retrotransposition from their parent gene and can be categorized as unitary, unprocessed (duplicated), or processed pseudogenes[2][11]. MPPE1P2 is not believed to produce a functional protein or possess direct biological activity such as that of an enzyme or receptor. Pseudogenes can sometimes have regulatory effects on their parent genes or participate in gene expression regulation (for example, acting as competing endogenous RNAs), but there is no current evidence of MPPE1P2 fulfilling a therapeutic target role or being implicated in disease[2][3]. **Key points:** - MPPE1P2 is not a therapeutic target and should not be confused with the parent gene, Metallophosphoesterase 1 (MPPE1), which is a functional enzyme involved in GPI-anchor protein transport[1][7]. - Pseudogenes are generally classified outside conventional molecular classifications like receptors, enzymes, transporters, etc.[2][11]. - There is no record of drugs, biomarkers, or safety concerns directly related to MPPE1P2. **Errors or mismatch:** - MPPE1P2 is not a valid therapeutic target; it is a pseudogene and not a protein-coding entity nor a functional molecule for intervention[2][11]. - No interacting drugs, mechanisms, or established disease roles are associated. **Summary:** MPPE1 pseudogene 2 (MPPE1P2) is a human pseudogene related to the functional MPPE1 gene, with no protein product or established therapeutic significance. It should not be listed as a druggable or disease-associated target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MPPE1 pseudogene 2 (MPPE1P2).